Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1775 plus paclitaxel in TP53-mutant advanced gastric adenocarcinoma (second-line)
KCT0004071Phase 2Recruiting
- Sponsor
- Samsung Medical Center
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adavosertib in gastric adenocarcinoma, sponsored by Samsung Medical Center. Started Feb 2015; status: recruiting.
02
Drugs
adavosertib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on KCT0004071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004071.